title: Shelf-life extension of azacitidine: waste and cost reduction in the treatment of myelodysplastic syndromes.
authors.affiliation: Hematology/Oncology.
authors.forename: Hany R
authors.initials: HR
authors.lastname: Guirguis
authors.forename: Lauren F
authors.initials: LF
authors.lastname: Charbonneau
authors.forename: Ivan
authors.initials: I
authors.lastname: Tyono
authors.forename: Richard A
authors.initials: RA
authors.lastname: Wells
authors.forename: Matthew C
authors.initials: MC
authors.lastname: Cheung
authors.forename: Rena
authors.initials: R
authors.lastname: Buckstein
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000964:Antimetabolites, Antineoplastic / Q000191:economics / Q000627:therapeutic use; D001374:Azacitidine / Q000191:economics* / Q000627:therapeutic use; D017046:Cost Savings; D003362:Cost-Benefit Analysis; D004339:Drug Compounding / Q000379:methods; D016527:Drug Costs; D004355:Drug Stability; D004356:Drug Storage / Q000379:methods; D005260:Female; D005615:Freezing; D006801:Humans; D008297:Male; D017744:Medical Waste Disposal / Q000191:economics* / Q000706:statistics & numerical data; D008875:Middle Aged; D009190:Myelodysplastic Syndromes / Q000188:drug therapy / Q000191:economics*; D017063:Outcome Assessment, Health Care / Q000191:economics
chemical_list: D000964:Antimetabolites, Antineoplastic; D017744:Medical Waste Disposal; D001374:Azacitidine